POSTER: ABCL-142: Golcadomide—A Potential First-in-Class Oral CELMoD Combined With Pola-R-CHP in Frontline Aggressive B-Cell Lymphoma: Safety and 12-Month Efficacy
Year: 2026
Type: article
Authors: Muhamad Alhaj Moustafa, Theodoros Vassilakopoulos, Grzegorz Nowakowski, Michal Kwiatek, Maria Bouzani, Dagmara Zimowska-Curylo, Alejandro Martín García-Sancho, Juan-Manuel Sancho, Wojciech Jurczak, Arpankumar Patel, Floriane Boucaud, Argyrios Gkasiamis, Mark Kaplan, Arnaud Amzallag, Matt Stokes, Tanvi Jindia, Serena Perna, Marc Hoffmann
Institutions: Mayo Clinic in Florida, National and Kapodistrian University of Athens, Laiko General Hospital of Athens, Mayo Clinic, Poznan University of Medical Sciences, Evangelismos Hospital, Szpital Uniwersytecki w Krakowie, Universidad de Salamanca, Instituto de Investigación Biomédica de Salamanca, Centro de Investigación Biomédica en Red de Cáncer, Hospital Universitari Germans Trias i Pujol, Bristol-Myers Squibb (United States), The University of Kansas Cancer Center
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7204686140
FWCI:
Cites:
Cited by:
Related to: